Connect with:
Thursday / March 28. 2024
HomeInputsAgro chems – ChemicalsRallis India posts Rs 863 Cr revenues in Q1 FY22-23

Rallis India posts Rs 863 Cr revenues in Q1 FY22-23

source- public domain

 Company witnessed a strong growth of 16.5 per cent in revenue on the back of 17.1 per cent growth in domestic crop care business and 51 per cent growth in exports.

Rallis India Limited, a TATA Enterprise and a leading player in the Indian Agri inputs industry announced its financial results for the first quarter of the financial year starting April 2022.

Announcing the results, Sanjiv Lal, Managing Director, and CEO, Rallis India said, “In Q1, we witnessed a strong growth of 16.5 per cent in revenue on the back of 17.1 per cent growth in domestic crop care business and 51 per cent growth in exports. However, we faced cost headwinds which affected our margins. In the seeds business, there were challenges of delayed monsoon and crop shifts. The revival of monsoons in July augurs well for agriculture.”

He also added that our long-term focus continues to be investing in growth through new product introduction, expanding our retail footprint and investing in flexible Multipurpose manufacturing plants for multiple chemistry capabilities required for our new product pipeline.

Key Highlights – Q1

The Company recorded revenues of ₹ 863 Cr for the quarter ending 30 June 2022, an increase of 16.5 per cent over PY of Rs 741 Cr. Profit before tax (before exceptional items) was at Rs 90 Cr as compared to PY of profit before tax (before exceptional item) of Rs 109 Cr and the Profit after tax (after exceptional items) was Rs 67 Cr, as compared to PY profit after tax (after exceptional item) of Rs 82 Cr.

Key Developments

With the announcement of CAPSTONE, Rallis India became the first company in India to introduce FENOXANIL

Launched 1 new herbicide for Cotton and Paddy crops each, 3 new Paddy hybrids and a Tomato hybrid

Received product registrations for ‘Daksh Plus’ – a Wheat herbicide – and ‘Clasto’ – a Cotton insecticide

No comments

leave a comment